Third Rock Ventures IV, L.P. - 10%+ Owner at Dianthus Therapeutics, Inc. /DE/

Issuer-level insider activity

Role
10%+ Owner
Issuer ticker
DNTH on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Company
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Third Rock Ventures IV, L.P. since 18 Aug 2025

Reported holdings for Third Rock Ventures IV, L.P. in Dianthus Therapeutics, Inc. /DE/

Form 4 holding 10%+ Owner

Magenta Therapeutics, Inc.

Security class
Common Stock
Shares / value
3,058,204
Estimated value
$36,698,448
Report date
08 Feb 2023
Price
$12.00
Ownership
Direct

Transaction history for Third Rock Ventures IV, L.P. in Dianthus Therapeutics, Inc. /DE/

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .